{"id":"https://openalex.org/W7204732370","doi":"https://doi.org/10.1016/s2152-2650(26)01298-x","title":"POSTER: MM-263: Reduced-Frequency Dosing of FDA-Approved Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Maintaining Efficacy While Reducing Infection-Related Toxicity","display_name":"POSTER: MM-263: Reduced-Frequency Dosing of FDA-Approved Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Maintaining Efficacy While Reducing Infection-Related Toxicity","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204732370","doi":"https://doi.org/10.1016/s2152-2650(26)01298-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01298-x","doi":"https://doi.org/10.1016/s2152-2650(26)01298-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01298-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068204824","display_name":"Mahboob Younus Shaik","orcid":"https://orcid.org/0009-0000-9438-6589","observed_orcids":["https://orcid.org/0009-0000-9438-6589"]},"institutions":[{"id":"https://openalex.org/I4210124418","display_name":"CHI St. Vincent","ror":"https://ror.org/02tr0ps12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahboob Younus Shaik","raw_affiliation_strings":["CHI St Vincent Hospital, Hot Springs, AR, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHI St Vincent Hospital, Hot Springs, AR, United States of America","institution_ids":["https://openalex.org/I4210124418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108885836","display_name":"Sana Dugan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124418","display_name":"CHI St. Vincent","ror":"https://ror.org/02tr0ps12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sana Dugan","raw_affiliation_strings":["CHI St Vincent Hospital, Hot Springs, AR, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHI St Vincent Hospital, Hot Springs, AR, United States of America","institution_ids":["https://openalex.org/I4210124418"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5148721079","display_name":"Ashley Jenkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124418","display_name":"CHI St. Vincent","ror":"https://ror.org/02tr0ps12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashley Jenkins","raw_affiliation_strings":["CHI St Vincent Hospital, Hot Springs, AR, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHI St Vincent Hospital, Hot Springs, AR, United States of America","institution_ids":["https://openalex.org/I4210124418"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210124418"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S333","last_page":"S333"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.996999979019165},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.42399999499320984},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.3089999854564667},{"id":"https://openalex.org/keywords/fda-approved-drugs","display_name":"FDA-approved drugs","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9661999940872192},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6830999851226807},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.646399974822998},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.571399986743927},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4745999872684479},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4300999939441681},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.351500004529953},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.33469998836517334},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3118000030517578},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28049999475479126},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26669999957084656},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2632000148296356},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.2551000118255615},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.25380000472068787}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01298-x","doi":"https://doi.org/10.1016/s2152-2650(26)01298-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01298-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204699384","https://openalex.org/W7204706075","https://openalex.org/W4413791370","https://openalex.org/W7204709460","https://openalex.org/W7204712211","https://openalex.org/W7204696678","https://openalex.org/W4414303695","https://openalex.org/W4413791128","https://openalex.org/W7204733189","https://openalex.org/W7204699122"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}